Skip to content

Fluorescence Imaging on the da Vinci Surgical System for Intraoperative Near Infrared Imaging

A Prospective Investigation of the Use of the Fluorescence Imaging on the da Vinci Surgical System for Intraoperative Near Infrared Imaging of Renal Cortical Tumors

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01104389
Enrollment
0
Registered
2010-04-15
Start date
2010-05-31
Completion date
Unknown
Last updated
2015-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Renal Tumors

Brief summary

A Prospective Investigation of the Use of the Fluorescence Imaging on the da Vinci Surgical System for Intraoperative Near Infrared Imaging of Renal Cortical Tumors. To determine the feasibility of the fluorescence imaging on the da Vinci Surgical System in robotic partial nephrectomy procedures and report perioperative outcomes.

Interventions

Intraoperatively acquire fluorescence images of renal tumors

Sponsors

Intuitive Surgical
Lead SponsorINDUSTRY

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Ages of 18 to 80 years. * Urine pregnancy test negative for women of childbearing potential prior to surgery * Subject is able to comply with the study procedures * A CT or MRI preoperative assessment of renal cortical tumor * The renal tumor must be stage T1a-b - T2 * Written informed consent.

Exclusion criteria

* Subject has significant liver disease, cirrhosis or liver insufficiency with abnormal liver function tests, as total bilirubin \>1.5 X normal and/or SGOT \>2X normal * Subject has uremia, serum creatinine \>2.0 mg/dl. * Subject has a previous history of adverse reaction or allergy to ICG, iodine, shellfish or iodine dyes * Subject in whom the use of x-ray dye or ICG is contraindicated including development of adverse events when previously or presently administered * Subject has any medical condition, which in the judgment of the Investigator and/or designee makes the subject a poor candidate for the investigational procedure * Subject is pregnant or lactating * Subjects actively participating in another drug, biologic and/or device protocol * The presence of medical conditions contraindicating general anesthesia or standard surgical approaches.

Design outcomes

Primary

MeasureTime frameDescription
The rate of good or excellent fluorescence images achieved intraoperatively. It will be measured by the correlation of the ultrasound imaging with the fluorescence imaging.IntraoperativelyThe feasibility of using the fluorescence imaging on the da Vinci Surgical System to detect renal cortical tumors will be measured by the rate of good or excellent images achieved intraoperatively.

Secondary

MeasureTime frame
Include but not limited to the rate of positive surgical margins, incidence of complications, estimated blood loss and length of stay.up to 3 weeks postoperatively

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026